Open access
Aug 2026
Cost-effectiveness and budget impact analyses of introducing typhoid conjugate vaccine into Indonesia's national immunisation program.
Introducing TCV into Indonesia's NIP is projected to be very cost-effective, and adding a catch-up campaign is an optimal strategy with greater public health impact while remaining very cost-effective.
J. Haposan, J. A. Thobari, Emma Watts et al.
· Vaccine · 0 citations